Trial Profile

A Randomized Trial of Standard vs Half-Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amoxicillin (Primary) ; Clarithromycin (Primary) ; Metronidazole (Primary) ; Rabeprazole (Primary) ; Helicobacter pylori eradication therapies
Indications Helicobacter pylori infections
Focus Therapeutic Use

Most Recent Events

09 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
09 Jan 2013 Planned end date changed from 1 Aug 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov record.
24 Oct 2012 Preliminary results presented at the 77th Annual Scientific Meeting of the American College of Gastroenterology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com